Literature DB >> 20493473

Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5α-reductase-2 deficiency.

Keiko Matsubara1, Hideki Iwamoto, Atsumi Yoshida, Tsutomu Ogata.   

Abstract

OBJECTIVE: To report semen parameters and successful paternity by intracytoplasmic sperm injection (ICSI) in a male patient with molecularly confirmed steroid 5α-reductase-2 deficiency.
DESIGN: Case report.
SETTING: National research institute and an infertility clinic. PATIENT(S): A 29-year-old Japanese man with 5α-reductase-2 deficiency who had failed to have a child despite an ordinary conjugal life for 2 years with his wife. INTERVENTION(S): Mutation analysis, semen analysis, and execution of ICSI. MAIN OUTCOME MEASURE(S): Mutation detection, semen assessment, and production of a child. RESULT(S): Mutation analysis revealed a homozygous p.R246Q missense mutation on exon 5 of SRD5A2. Semem analysis showed oligozoospermia (semen volume 0.3 mL, sperm count 15 × 10(6)/mL, total sperm count 4.5 × 10(6), motile cells 17%, and normal morphologic sperm 8%). ICSI resulted in a production of a healthy male infant. CONCLUSION(S): The results, in conjunction with those of previously reported patients who received semen analysis and/or achieved paternity, suggest that male patients with 5α-reductase-2 deficiency, especially those with hypomorphic mutations including p.R246Q, could retain some degree of spermatogenic function and achieve paternity with and without assisted reproductive technology.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493473     DOI: 10.1016/j.fertnstert.2010.04.013

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population.

Authors:  Meshael M Alswailem; Ohoud S Alzahrani; Lamyaa Alghofaili; Ebtesam Qasem; Mai Almohanaa; Afaf Alsagheir; Bassam Bin Abbas; Najya A Attia; Adnan Al Shaikh; Ali S Alzahrani
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

2.  Histological analysis of testes in patients with 5 alpha-reductase deficiency type 2: Comparison with cryptorchid testes in patients without endocrinological abnormalities and a review of the literature.

Authors:  Tamaki Wada; Chihiro Ichikawa; Makoto Takeuchi; Futoshi Matsui; Fumi Matsumoto; Shinobu Ida; Yuri Etani; Masanobu Kawai
Journal:  Clin Pediatr Endocrinol       Date:  2022-06-03

Review 3.  Psychological aspects of the treatment of patients with disorders of sex development.

Authors:  David E Sandberg; Melissa Gardner; Peggy T Cohen-Kettenis
Journal:  Semin Reprod Med       Date:  2012-10-08       Impact factor: 1.303

4.  Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients.

Authors:  Lavinia Vija; Sophie Ferlicot; Diana Paun; Hélène Bry-Gauillard; Gabriela Berdan; Issam Abd-Alsamad; Marc Lombès; Jacques Young
Journal:  BMC Endocr Disord       Date:  2014-05-23       Impact factor: 2.763

5.  Preservation of Fertility Potential for Gender and Sex Diverse Individuals.

Authors:  Emilie K Johnson; Courtney Finlayson
Journal:  Transgend Health       Date:  2016-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.